Your browser doesn't support javascript.
loading
16α-Bromoepiandrosterone as a new candidate for experimental diabetes-tuberculosis co-morbidity treatment.
López-Torres, Manuel Othoniel; Marquina-Castillo, Brenda; Ramos-Espinosa, Octavio; Mata-Espinosa, Dulce; Barrios-Payan, Jorge A; Baay-Guzman, Guillermina; Yepez, Sara Huerta; Bini, Estela; Torre-Villalvazo, Ivan; Torres, Nimbe; Tovar, Armando; Chamberlin, William; Ge, Yu; Carranza, Andrea; Hernández-Pando, Rogelio.
Affiliation
  • López-Torres MO; Experimental Pathology Section, Department of Pathology, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico.
  • Marquina-Castillo B; Experimental Pathology Section, Department of Pathology, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico.
  • Ramos-Espinosa O; Experimental Pathology Section, Department of Pathology, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico.
  • Mata-Espinosa D; Experimental Pathology Section, Department of Pathology, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico.
  • Barrios-Payan JA; Experimental Pathology Section, Department of Pathology, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico.
  • Baay-Guzman G; Oncological Diseases Research Unit, Hospital Infantil de Mexico 'Federico Gomez', Mexico City, Mexico.
  • Yepez SH; Oncological Diseases Research Unit, Hospital Infantil de Mexico 'Federico Gomez', Mexico City, Mexico.
  • Bini E; Experimental Pathology Section, Department of Pathology, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico.
  • Torre-Villalvazo I; Physiology of Nutrition Department, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico.
  • Torres N; Physiology of Nutrition Department, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico.
  • Tovar A; Physiology of Nutrition Department, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico.
  • Chamberlin W; Protibea Therapeutics LLC, Naples, Florida, USA.
  • Ge Y; Protibea Therapeutics LLC, Naples, Florida, USA.
  • Carranza A; CONICET - Universidad de Buenos Aires, Instituto Alberto C. Taquini de Investigaciones en Medicina Traslacional (IATIMET, Buenos Aires, Argentina.
  • Hernández-Pando R; Experimental Pathology Section, Department of Pathology, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico.
Clin Exp Immunol ; 205(2): 232-245, 2021 08.
Article in En | MEDLINE | ID: mdl-33866550
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Tuberculosis / Diabetes Mellitus, Experimental / Hypoglycemic Agents / Androsterone / Antitubercular Agents Type of study: Prognostic_studies Limits: Animals Language: En Journal: Clin Exp Immunol Year: 2021 Document type: Article Affiliation country: Mexico Country of publication: United kingdom
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Tuberculosis / Diabetes Mellitus, Experimental / Hypoglycemic Agents / Androsterone / Antitubercular Agents Type of study: Prognostic_studies Limits: Animals Language: En Journal: Clin Exp Immunol Year: 2021 Document type: Article Affiliation country: Mexico Country of publication: United kingdom